Journal of antivirals and antiretroviral is one of the top journals in the current field of virology which publishes novel work in the form of different article types such as research or review articles. This journal acts as a barrier for exchange of scientific knowledge among researchers and scientists.
This mainly involves in the discovery and development of antiretroviral drugs, to prolong life of the humans and discovers compounds, and clinical methods to prevent viral infections. Importantly, it provides the opportunity to study about antiretrovirals, ant-HIV drugs and HIV antiviral drugs in the field of virology.
OMICS Group offers an opportunity and a forum of Open Access Scholarly Published Articles (OASPA) for bringing together all the scientific communities of Open Access journal publishers. The main mission is to expose, spread the areas of Open Access (OA) journals and book publishers globally in all Fields such as environmental, Life sciences, clinical, technical, engineering models and scholarly disciplines. The goal to spread knowledge via exchanging information from subject to subject, easy access through information technologies, setting standards, Innovative models, and promoting innovation. We can ensure a prosperous and sustainable future to the benefit of our members and the scholarly communities they serve.
Authors have an opportunity to use the newly launched Translation Services. Experienced translators translate the submission to the required native languages such as French, German, Spanish, Chinese, Japanese or English. Therefore, we guarantee the best exchange of knowledge and expertise to your targeted audience. The translation process is always followed by strict review procedures to ensure absolute accuracy. This guarantees free communication and exchange between scientists and creates more opportunities for future research on around the world.
Last date updated on March, 2021